Yoo Joseph, Kistler C Andrew, Yan Linda, Dargan Andrew, Siddiqui Ali A
Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USA; Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
J Gastrointest Oncol. 2016 Dec;7(6):1019-1029. doi: 10.21037/jgo.2016.08.07.
Endoscopic ultrasound (EUS) has become a mainstay in assisting in the diagnosis and staging of pancreatic cancer. In addition, EUS provides a modality to treat chronic pain through celiac plexus neurolysis. Currently, there is growing data and utilization of EUS in more diverse and innovative applications aimed at providing more sophisticated diagnostic, prognostic and therapeutic options for patients with pancreatic cancer. EUS delivery of chemotherapy, viral and biological vectors and fiducial markers may eventually revolutionize the way clinicians approach the care of a patient with pancreatic cancer.
内镜超声(EUS)已成为辅助胰腺癌诊断和分期的主要手段。此外,EUS还提供了一种通过腹腔神经丛神经溶解术治疗慢性疼痛的方法。目前,越来越多的数据表明EUS在更多样化和创新性应用中的使用,旨在为胰腺癌患者提供更精密的诊断、预后和治疗选择。EUS递送化疗药物、病毒和生物载体以及基准标记物最终可能会彻底改变临床医生治疗胰腺癌患者的方式。